ReviewHeart failure reviews2022
Ventricular non-compaction review.
Review in Heart failure reviews, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
32 citing papers in PubMed, 1 synthesis or guideline pooled it, 50 citations in OpenAlex.
- Predictors of fatal arrhythmic events in patients with non-compaction cardiomyopathy: a systematic review.Heart failure reviews · 2022Pooled it
- Endocardial transcription factor HAND2 orchestrates hypoxic and TGF-β signaling to modulate coronary artery formation.The Journal of clinical investigation · 2026Article
- Left Ventricular Hypertrabeculation: Historical Evolution, Diagnostic Pitfalls, and a Pragmatic Clinical Approach.Reviews in cardiovascular medicine · 2026Review
- Physiological Pacing and Cardiomyopathies: A Future Ahead.JACC. Case reports · 2026Article
- Left Ventricular Non-Compaction Cardiomyopathy: The Tragedies & Trabeculations of the Architectural Cardiac Sponge.Journal of clinical medicine · 2026Review
- The spongy heart paradox: balancing bleeding and clotting risk in left ventricular noncompaction cardiomyopathy.Heart failure reviews · 2026Review
- Clinical phenotypes across age groups and the predictive value of NT-proBNP for ventricular arrhythmias in left ventricular non-compaction: a multicenter cohort study.Journal of translational medicine · 2026Article
- Case Report: Hereditary ATTR-CA presenting with recurrent severe abdominal cramps: a diagnostic challenge.Frontiers in cardiovascular medicine · 2026Article
- Novel mutation associated with non-compaction ventricular myocardium: A case report.ESC heart failure · 2025Article
- A concise guide of contemporary cardiovascular imaging practices to differentiate athlete's heart in the gray zone.Heart failure reviews · 2025Review
- Article
- Patterns of left ventricular trabeculation in hypertrophic cardiomyopathy.BMC medicine · 2025Article
- Clinical features of non-compaction cardiomyopathy across age groups: a retrospective study of 415 patients.Open heart · 2025Article
- Throwing thrombi: noncompaction cardiomyopathy causing renal infarct and catastrophic stroke - a case report.BMC cardiovascular disorders · 2025Article
- The Role of theGenes · 2025Article
- Case Report: Multimodality imaging of a congenital ventricular septal aneurysm complicated by biventricular myocardial non-compaction in a child.Frontiers in pediatrics · 2025Article
- The Role of Echocardiography in the Diagnosis of Left Ventricular Noncompaction: Usefulness in a Resource-Constrained Setting.Clinical case reports · 2024Article
- Article
- The Role of Cardiovascular Imaging in the Diagnosis of Athlete's Heart: Navigating the Shades of Grey.Journal of imaging · 2024Review
- Left Ventricular Non-compaction Cardiomyopathy: A Report of a Rare Case From Saudi Arabia.Cureus · 2024Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Left ventricular non-compaction cardiomyopathy (LVNC) is a rare and unclassified cardiomyopathy that carries the potential to cause heart failure, arrhythmias, and embolic events within adults. The diagnosis of this cardiomyopathy can be based off a variety of echocardiographic, cardiac magnetic resonance (CMR), and computed tomography (CT) imaging criteria; none of which have been standardized to establish a firm diagnosis. This is further complicated by the observation from prior studies that LVNC may present as different forms of cardiomyopathy, each with its own subset of nuances that may change treatment strategies. Management of such cardiomyopathy has been debated in terms of anticoagulation, electrophysiologic studies to prevent arrhythmia, as well as heart failure prevention. Not enough data exists in regard to establishing firm guidelines for management. The following article aims to provide a comprehensive review in regard to the etiologies, pathogenesis, diagnostic criteria, management, and treatment of LVNC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.